Acquired
Novo Nordisk (Ozempic)
Ben Gilbert
Which, by the way, on earnings calls, the company says, yeah, that's going to be true for a long time. The demand for this drug will continue to massively outpace our supply. And we will be here on earnings calls over and over and over again telling you that no matter how many factories we build, we are supply constrained still.
0
💬
0
Comments
Log in to comment.
There are no comments yet.